================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
--------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
July 22, 2003
--------------------
BOSTON SCIENTIFIC CORPORATION
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
DELAWARE 1-11083 04-2695240
--------------------------------------------------------------------------------
(State or other (Commission (IRS employer
jurisdiction of file number) identification no.)
incorporation)
One Boston Scientific Place, Natick, Massachusetts 01760-1537
-------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (508) 650-8000
================================================================================
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
99.1 Press Release issued by Boston Scientific Corporation dated
July 22, 2003.
ITEM 9. REGULATION FD DISCLOSURE.
On July 22, 2003, Boston Scientific Corporation (the "Company") issued a
press release announcing financial results for the second quarter ended June 30,
2003. A copy of the release is furnished with this report as an exhibit pursuant
to "Item 12. Results of Operations and Financial Condition" of Form 8-K in
accordance with SEC Release Nos. 33-8216 and 34-47583.
The information in this Current Report on Form 8-K and the Exhibit attached
hereto shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act, regardless of
any general incorporation language in such filing.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
BOSTON SCIENTIFIC CORPORATION
Date: July 22, 2003 By: /s/ Lawrence J. Knopf
-------------------------
Lawrence J. Knopf
Vice President and Assistant General Counsel